SEC Form 4 · accession 0001437749-15-018005
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles K Dargan
Officer — Chief Financial Officer
Period of report
Sep 30, 2015
Accepted (ET)
Oct 2, 2015 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StoockF2,F1 | $0.57 | Sep 30, 2015 | A | 300,000 | A | Sep 30, 2015 | Sep 30, 2025 | Common Stock | 300,000 | 2,446,000 | D |
Explanation of responses
- F1This Option vests pursuant to following schedule: 125,000 shares immediately, and 15,000 shares per month beginning October 1, 2015; vesting occurs on those dates so long as Reporting Person is engaged as Issuer's Chief Financial Officer.
- F2This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2015 through September 30, 2016.